Thai healthcare solutions company Zuellig Pharma has announced that Mounjaro (tirzepatide), Eli Lilly’s (NYSE: LLY) ...

Sybos Holdings, a unit of Zuellig Group, said it had entered into a block trade agreement with a financial institution to ...

Zuellig Pharma introduces Eli Lilly’s innovative obesity and diabetes medicine, Mounjaro in Thailand: Bangkok, Thailand Thursday, May 29, 2025, 11:00 Hrs [IST] Zuellig Pharma, a ...

UBS launched a $NZ950 million ($880 million) block trade in EBOS Group after-market on Wednesday on behalf of major ...

To bring the COVID-19 Vaccine Moderna to the Philippines and other Southeast Asian countries, last April 2021, Zuellig Pharma announced a partnership with Moderna Inc., a biotechnology company ...

5 February 2024 - Zuellig Pharma, a leading healthcare solutions company in Asia, has announced that it has completed the acquisition of two brands, Cialis® (Tadalafil) and Alimta® (Pemetrexed ...

New agreement marks major milestone for Zuellig Pharma as it focuses on expanding its consumer healthcare segment, and for Institut AllergoSan as it expands its global presence SINGAPORE - Media ...

BANGKOK, THAILAND – Media OutReach Newswire – 27 May 2025 – Zuellig Pharma, a leading healthcare solutions company in Asia, ...

BANGKOK, THAILAND - Media OutReach Newswire - 27 May 2025 - Zuellig Pharma, a leading healthcare solutions company in Asia, has announced that Mounja ...

(MENAFN- Dubai PR Network) Mounjaro (tirzepatide) will be available in the market from the end of May 2025 BANGKOK, THAILAND - Media OutReach Newswire - 27 May 2025 - Zuellig Pharma, a leading ...